Patients 3 ways to make 2024 the year of the patient Clinical research is never just about the next year; it's always about the next several years.
Digital Retaining the human element of AI within pharma and healthca... Artificial intelligence (AI) has been the word of 2023, but aside from the promises, what are the realities of its practical implementation in the life sciences setting?
Partner Content Partner Content The ryze-elluminate integration to maximise automation in cl... The ryze-elluminate integration
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
